Rahber A. Thariani, Ph.D.
Affiliations: | 2009 | University of Washington, Seattle, Seattle, WA |
Area:
Biomedical Engineering, General Biophysics, Optics PhysicsGoogle:
"Rahber Thariani"Parents
Sign in to add mentor| Paul Yager | grad student | 2009 | University of Washington | |
| (Imaging of surfaces by surface plasmon resonance and surface plasmon resonance-enhanced fluorescence.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ramsey SD, Henry NL, Gralow JR, et al. (2015) Tumor marker usage and medical care costs among older early-stage breast cancer survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 149-55 |
| Thariani R, Henry NL, Ramsey SD, et al. (2013) Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis. Journal of Comparative Effectiveness Research. 2: 325-34 |
| Carlson JJ, Thariani R, Roth J, et al. (2013) Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 33: 463-71 |
| Esmail LC, Roth J, Rangarao S, et al. (2013) Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 15: 115-22 |
| Thariani R, Veenstra DL, Carlson JJ, et al. (2012) Paying for personalized care: cancer biomarkers and comparative effectiveness. Molecular Oncology. 6: 260-6 |
| Thariani R, Wong W, Carlson JJ, et al. (2012) Prioritization in comparative effectiveness research: the CANCERGEN Experience. Medical Care. 50: 388-93 |
| Thariani R, Blough DK, Barlow W, et al. (2012) Evaluating the impact of a trial in breast cancer tumor markers: A value of research analysis. Journal of Clinical Oncology. 30: e16524-e16524 |
| Thariani R, Blough DK, Barlow W, et al. (2012) PCN153 A Trial for Evaluating Breast Cancer Tumor Marker Use Impact: A Value of Research Analysis Value in Health. 15 |
| Thariani R, Carlson J, Steuten LMG, et al. (2011) Pcn10 Are Further Studies Of Breast Cancer Tumor Markers To Detect Recurrence Worthwhile? A Value Of Research Analysis Value in Health. 14 |
| Carlson J, Thariani R, Roth J, et al. (2011) Pcn9 Value Of Research Analyses In Research Prioritization Of Cancer Genomic Applications Value in Health. 14 |